Other languages Revvity, Inc.

Equities

RVTY

US7140461093

Real-time Estimate Cboe BZX Other stock markets 12:14:15 2024-07-03 pm EDT			5-day change	1st Jan Change
102 ^USD	+0.03%		-2.21%	-6.67%

Jun. 27	Barclays Trims Price Target on Revvity to $115 From $116	MT
Jun. 20	Bionano Genomics Says Revvity to Commercialize VIA Software	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bionano Genomics Says Revvity to Commercialize VIA Software	Jun. 20
Bionano Genomics, Inc. Announces Software Marketing Agreement with Revvity, Inc. for Newborn Sequencing Research	Jun. 20
GenKOre Announces Strategic Collaboration with Revvity to Develop Innovative Gene Therapy Treatments	Jun. 18
Revvity beats quarterly estimates on demand for diagnostic equipment	Apr. 29
Revvity Q1 Adjusted Earnings, Revenue Down; Lowers 2024 Revenue Guidance	Apr. 29
Revvity, Inc. Updates Earnings Guidance for the Full Year 2024	Apr. 29
Revvity, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29
Revvity, Inc. Declares Quarterly Dividend, Payable on August 9, 2024	Apr. 25
Early Check Newborn Screening Study Taps Revvity to Provide Genome Sequencing	Apr. 25
Revvity Unveils A New Era of Automated Tuberculosis Testing	Apr. 24
Revvity Says Court Issued Preliminary Injunction Against Cloud Software Group	Apr. 02
Revvity Files Lawsuit Against Partner Cloud Software Group, Reaffirms 2024 Guidance	Mar. 20
Revvity, Inc. Re-Affirms Earnings Guidance for the Full Year 2024	Mar. 20
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication	Mar. 18
Revvity, Inc. Introduces New Workflow to Accelerate Newborn Sequencing Research	Mar. 15
Revvity Inc Receives a Shareholder Proposal from John Chevedden	Mar. 13
Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions	Feb. 12
Revvity Insider Sold Shares Worth $3,841,563, According to a Recent SEC Filing	Feb. 08
Revvity Insider Sold Shares Worth $1,613,697, According to a Recent SEC Filing	Feb. 07
RECOMENDACIONES DE LOS ANALISTAS EE.UU. : Alphabet, Meta Platforms, Amazon, Wise, Clorox...	Feb. 02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Revvity, Inc.

Equities

RVTY

US7140461093

Other languages

Filters